Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases

Details for Australian Patent Application No. 2009281197 (hide)

Owner GlaxoSmithKline LLC

Inventors Biggadike, Keith; Coe, Diane Mary; Lewell, Xiao Qing; Mitchell, Charlotte Jane; Smith, Stephen Allan; Trivedi, Naimisha

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009281197

PCT Pub. Number WO2010/018133

Priority 61/087,777 11.08.08 US

Filing date 7 August 2009

Wipo publication date 18 February 2010

International Classifications

C07D 473/18 (2006.01) Heterocyclic compounds containing purine ring systems

A61K 31/522 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07D 473/16 (2006.01) Heterocyclic compounds containing purine ring systems

Event Publications

24 February 2011 PCT application entered the National Phase

  PCT publication WO2010/018133 Priority application(s): WO2010/018133

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009281198-Novel adenine derivatives

2009281195-Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases